Strain Summary(C57BL/6N x C3H/HeN)F1
Strain Name |
(C57BL/6N x C3H/HeN)F1 |
Strain Type(s) |
hybrid |
Strain Synonym(s) |
B6C3F1 • B6C3F1 • BCF1 • C57BL/6NxC3H/HeN F1 • (C57BL/6N X C3H/HeN)F1 |
Description |
F1 generation of a cross between C57BL/6N female and C3H/HeN male mice. |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Adipose tissue lipoma | Peritoneal cavity |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Adipose tissue lipoma | Skin |
0.12 |
0.16 |
0.14 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adipose tissue lipoma | Urinary bladder |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adipose tissue lipoma | Ovary |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Adipose tissue liposarcoma | Peritoneal cavity |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Adipose tissue liposarcoma | Skin | calorie restricted |
33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Adipose tissue liposarcoma | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Adipose tissue liposarcoma | Skin |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
0 - 7.1 |
0.4 - 12.5 |
0.45 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | calorie restricted |
2.5 - 6.7 |
2.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Adrenal gland - Cortex carcinoma | Adrenal gland - Cortex |
0 |
0.12 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0.28 - 14.3 |
0.31 - 1.2 |
0.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla | calorie restricted |
2.5 - 13.3 |
4.7 - 11.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Adrenal gland hyperplasia | Adrenal gland |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Adrenal gland hyperplasia - focal | Adrenal gland |
5.15 |
3.85 |
4.5 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Adrenal gland preneoplastic lesion | Adrenal gland |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ampullary gland adenocarcinoma | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Ampullary gland adenoma | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Ampullary gland cyst - mucinous | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Ampullary gland lesion - neoplastic | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Ampullary gland metaplasia - mucinous | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Ampullary gland tumor | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Ampullary gland tumor - granular cell | Ampullary gland |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Blood vessel hemangioma | Liver |
1.9 |
0 |
observed |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Blood vessel hemangioma | Liver | Cyclosporin A |
0 |
0.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel hemangioma | Liver | X-radiation |
1.0 |
0.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel hemangioma | Liver | X-radiation ⋅ Cyclosporin A |
0.5 |
1.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel hemangioma | Blood vessel |
0.79 - 4.5 |
1.3 - 6.1 |
1.05 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Blood vessel hemangioma | Spleen |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangioma | Skin |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangioma | Lymph node |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangioma | (Unspecified organ) |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangiosarcoma | Liver |
2.3 |
7.0 |
observed |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Blood vessel hemangiosarcoma | Liver | Cyclosporin A |
0.5 |
4.7 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel hemangiosarcoma | Liver | X-radiation |
1.0 |
6.2 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel hemangiosarcoma | Liver | X-radiation ⋅ Cyclosporin A |
1.9 |
4.3 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel hemangiosarcoma | Blood vessel |
1.11 - 3.7 |
1.61 - 2.5 |
1.36 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 Sites of Metastasis: (Unspecified organ) |
|||
| Blood vessel hemangiosarcoma | Prostate gland - Dorsolateral lobe |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Blood vessel hemangiosarcoma | Spleen |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangiosarcoma | Skin |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangiosarcoma | Lymph node |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel hemangiosarcoma | (Unspecified organ) |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Blood vessel neoplasm | Blood vessel |
0 - 15.4 |
0 - 31.25 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Blood vessel neoplasm | Blood vessel | calorie restricted |
0 - 20.0 |
0 - 100 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Blood vessel tumor | Liver |
3.8 |
7.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Blood vessel tumor | Liver | Cyclosporin A |
0.5 |
5.2 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel tumor | Liver | X-radiation |
1.9 |
6.7 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Blood vessel tumor | Liver | X-radiation ⋅ Cyclosporin A |
2.4 |
5.2 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Bone osteochondroma | Bone |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Bone osteoma | Lung |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Bone osteosarcoma | Bone |
0.16 - 50.0 |
0.04 - 5.3 |
0.10 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Bone osteosarcoma | Bone | calorie restricted |
2.5 - 33.3 |
5.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Bone osteosarcoma | Skin |
0.04 |
0.04 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Bone osteosarcoma | Lung |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| CNS - Brain - Oligodendroglial cell oligodendroglioma | CNS - Brain - Oligodendroglial cell |
0.04 |
0 - 6.25 |
0.02 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| CNS - Brain glioma | CNS - Brain |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| CNS - Meninges meningioma | CNS - Meninges |
0 |
0.08 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Connective tissue - Fibroblast fibroadenoma | Mammary gland |
0.12 |
0 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Connective tissue - Fibroblast fibroma | (Unspecified organ) |
0.4 |
2.5 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Connective tissue - Fibroblast fibroma | Skin |
0.04 |
0.31 |
0.18 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Connective tissue - Fibroblast fibroma | Pancreas |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Connective tissue - Fibroblast fibrosarcoma | Liver |
0 |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Connective tissue - Fibroblast fibrosarcoma | (Unspecified organ) |
0.8 |
2.9 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Skin |
0.56 - 3.1 |
0.87 - 12.5 |
0.71 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Connective tissue - Fibroblast fibrosarcoma | Skin | calorie restricted |
13.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Kidney |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Ear - Zymbal gland carcinoma | Ear - Zymbal gland |
7.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Esophagus papilloma | Esophagus |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Esophagus squamous cell carcinoma | Esophagus |
0 - 0.04 |
0.04 - 0.4 |
0.04 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Eye - Harderian gland adenocarcinoma | Eye - Harderian gland |
0 - 5.9 |
0.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Eye - Harderian gland adenoma | Eye - Harderian gland |
0.44 - 35.7 |
0.75 - 28.6 |
0.59 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Eye - Harderian gland adenoma | Eye - Harderian gland | calorie restricted |
2.9 - 20.0 |
3.7 - 23.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Eye - Harderian gland carcinoma | Eye - Harderian gland |
4.8 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 - 35.7 |
0 - 28.6 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Eye - Harderian gland neoplasm | Eye - Harderian gland | calorie restricted |
0 - 20.0 |
0 - 23.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Eye - Lacrimal gland adenoma | Eye - Lacrimal gland |
0.08 |
0.16 |
0.12 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Eye melanoma - malignant | Eye |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Forestomach squamous cell carcinoma | Forestomach |
0.8 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Forestomach squamous cell papilloma | Forestomach |
0.8 |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Intestine - Large Intestine carcinoma | Intestine - Large Intestine |
12.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Intestine - Large Intestine polyp | Intestine - Large Intestine |
12.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Intestine - Small Intestine adenocarcinoma | Intestine - Small Intestine |
0.04 |
0.28 |
0.16 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Intestine - Small Intestine adenoma | Intestine - Small Intestine |
0.04 |
0.16 |
0.1 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Intestine - Small Intestine polyp | Intestine - Small Intestine |
1.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Intestine - Small Intestine polyp | Intestine - Small Intestine | calorie restricted |
3.8 - 10.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Kidney - Cortex adenocarcinoma | Kidney - Cortex | calorie restricted |
2.5 |
3.7 - 3.8 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Kidney - Cortex adenoma | Kidney - Cortex | calorie restricted |
2.5 - 6.7 |
5.3 - 23.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Kidney - Cortex adenoma | Kidney - Cortex |
14.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Kidney - Renal tubule adenocarcinoma - tubular | Kidney - Renal tubule |
0.08 |
0.04 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Kidney - Renal tubule adenoma - tubular | Kidney - Renal tubule |
0 |
0.08 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Kidney neoplasm | Kidney |
0 |
0 - 14.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Kidney neoplasm | Kidney | calorie restricted |
0 - 5.5 |
0 - 25.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Kidney transitional cell carcinoma | Kidney |
0 |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Leukocyte - Lymphocyte hyperplasia | Prostate gland - Dorsolateral lobe |
26.97 - 42.18 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Prostate gland - Anterior lobe |
10.08 - 26.03 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Prostate gland - Ventral lobe |
28.46 - 38.46 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Seminal vesicle |
10.74 - 27.78 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Ampullary gland |
0 - 10.42 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte lymphoma | Prostate gland - Dorsolateral lobe |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte lymphoma | Prostate gland - Anterior lobe |
0 - 2.74 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte lymphoma | Prostate gland - Ventral lobe |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte lymphoma | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte lymphoma | Ampullary gland |
0 - 9.09 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Lymphocyte lymphoma | Lymph node |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Lymphocyte lymphoma | Spleen |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Lymphocyte lymphoma | Liver |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Lymphocyte lymphoma | Peyer's patch |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Lymphocyte lymphoma - lymphocytic | Leukocyte - Lymphocyte |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Lymphocyte lymphoma - mixed | Leukocyte - Lymphocyte |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
0 - 15.8 |
0 - 28.6 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | Cyclosporin A |
3.8 |
6.1 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | X-radiation |
4.9 |
1.9 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | X-radiation ⋅ Cyclosporin A |
2.4 |
4.8 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | calorie restricted |
0 - 15.0 |
0 - 44.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Prostate gland - Dorsolateral lobe |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell | calorie restricted |
33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | (Unspecified organ) |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Leukocyte - Myelocyte (Granulocyte) leukemia | Leukocyte - Myelocyte (Granulocyte) |
12.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Leukocyte - Myelocyte (Granulocyte) leukemia | Leukocyte - Myelocyte (Granulocyte) | calorie restricted |
50.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
0 |
0.24 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | Cyclosporin A |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | X-radiation |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | X-radiation ⋅ Cyclosporin A |
0.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Leukocyte leukemia | Prostate gland - Dorsolateral lobe |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte leukemia | Prostate gland - Ventral lobe |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte leukemia | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Leukocyte leukemia | Lymph node |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte leukemia | Spleen |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte leukemia | Liver |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte leukemia | (Unspecified organ) |
16.77 |
8.3 |
12.52 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Leukocyte lymphoma | Leukocyte |
0 - 84.2 |
0 - 50.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Leukocyte lymphoma | Leukocyte | Cyclosporin A |
52.4 |
19.8 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Leukocyte lymphoma | Leukocyte | X-radiation |
42.2 |
18.1 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Leukocyte lymphoma | Leukocyte | X-radiation ⋅ Cyclosporin A |
56.5 |
15.7 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Leukocyte lymphoma | Leukocyte | calorie restricted |
0 - 100 |
0 - 38.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Leukocyte lymphoma | (Unspecified organ) |
16.77 |
8.3 |
12.52 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Leukocyte lymphoma - histiocytic | Leukocyte |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Leukocyte tumor - malignant | Leukocyte |
23.6 |
14.3 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Liver - Sinusoid - Ito cell neoplasm | Liver - Sinusoid - Ito cell |
6.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Liver - Sinusoid - Ito cell tumor | Liver - Sinusoid - Ito cell |
0.9 |
1.4 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Liver - Sinusoid - Ito cell tumor | Liver - Sinusoid - Ito cell | Cyclosporin A |
0 |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver - Sinusoid - Ito cell tumor | Liver - Sinusoid - Ito cell | X-radiation |
0 |
1.9 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver - Sinusoid - Ito cell tumor | Liver - Sinusoid - Ito cell | X-radiation ⋅ Cyclosporin A |
0 |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver carcinoma - undifferentiated | Liver |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Liver hepatoblastoma | Liver |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||||
| Liver hepatoblastoma | Liver | Cyclosporin A |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Liver hepatoblastoma | Liver | X-radiation |
0.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Liver hepatoblastoma | Liver | X-radiation ⋅ Cyclosporin A |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Liver hepatocellular adenoma | Liver |
1.59 - 35.7 |
4.8 - 50.0 |
4.76 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Liver hepatocellular adenoma | Liver | Cyclosporin A |
5.2 |
14.6 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular adenoma | Liver | X-radiation |
2.4 |
16.7 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular adenoma | Liver | X-radiation ⋅ Cyclosporin A |
4.8 |
18.1 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular adenoma | Liver | calorie restricted |
5.0 - 20.0 |
2.3 - 20.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Liver hepatocellular carcinoma | Liver |
2.3 - 12.5 |
6.7 - 100 |
8.04 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 Sites of Metastasis: (Unspecified organ) , Abdominal cavity , Heart , Kidney , Lung , Lymph node - Mesenteric |
|||
| Liver hepatocellular carcinoma | Liver | Cyclosporin A |
1.9 |
21.7 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular carcinoma | Liver | X-radiation |
6.8 |
25.2 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular carcinoma | Liver | X-radiation ⋅ Cyclosporin A |
1.9 |
27.1 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular carcinoma | Liver | calorie restricted |
2.9 - 21.1 |
4.2 - 30.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 Sites of Metastasis: (Unspecified organ) |
|||
| Liver hepatocellular neoplasm | Liver |
3.9 - 12.0 |
21.6 - 35.9 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
||||
| Liver hepatocellular neoplasm | Liver | calorie restricted |
6.8 |
6.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Liver hepatocellular tumor | Liver |
10.3 |
29.6 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Liver hepatocellular tumor | Liver | Cyclosporin A |
7.1 |
34.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular tumor | Liver | X-radiation |
8.7 |
39.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatocellular tumor | Liver | X-radiation ⋅ Cyclosporin A |
6.7 |
41.9 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Liver hepatoma | Liver |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Liver hyperplasia - adenomatous | Liver |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Liver lesion | Liver |
10.2 |
48.0 |
observed |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Liver neoplasm | Liver |
0 - 42.9 |
16.3 - 53.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Liver neoplasm | Liver | calorie restricted |
0 - 33.3 |
0 - 20.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Liver tumor | Liver |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Lung - Alveolus hyperplasia - epithelial | Lung - Alveolus |
0.56 |
0.83 |
0.69 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Lung adenocarcinoma | Lung |
2.0 |
4.9 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Lung adenoma | Lung |
2.93 - 15.4 |
observed - 42.9 |
5.37 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Lung adenoma | Lung | Cyclosporin A |
4.7 |
13.2 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung adenoma | Lung | X-radiation |
3.9 |
21.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung adenoma | Lung | X-radiation ⋅ Cyclosporin A |
7.2 |
16.7 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung adenoma | Lung | calorie restricted |
5.0 - 33.3 |
7.1 - 33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Lung carcinoma | Lung |
1.51 - 7.0 |
observed - 50.0 |
observed - 3.28 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 Sites of Metastasis: (Unspecified organ) , Lymph node |
|||
| Lung carcinoma | Lung | Cyclosporin A |
2.4 |
16.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung carcinoma | Lung | X-radiation |
7.3 |
21.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung carcinoma | Lung | X-radiation ⋅ Cyclosporin A |
2.9 |
22.9 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung carcinoma | Lung | calorie restricted |
1.9 - 6.7 |
2.7 - 11.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 Sites of Metastasis: not (Unspecified organ) |
|||
| Lung carcinoma - acinar | Lung |
0.5 |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Lung carcinoma - acinar | Lung | Cyclosporin A |
0 |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung carcinoma - acinar | Lung | X-radiation |
0 |
0.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung carcinoma - acinar | Lung | X-radiation ⋅ Cyclosporin A |
0.5 |
0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung carcinoma - bronchioalveolar | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Lung hyperplasia | Lung |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Lung neoplasm | Lung |
0 - 13.7 |
12.7 - 71.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
||||
| Lung neoplasm | Lung | calorie restricted |
0 - 18.2 |
0 - 33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Lung preneoplastic lesion | Lung |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Lung tumor | Lung |
14.1 |
26.8 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
||||
| Lung tumor | Lung | Cyclosporin A |
7.1 |
28.3 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung tumor | Lung | X-radiation |
10.7 |
39.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lung tumor | Lung | X-radiation ⋅ Cyclosporin A |
10.0 |
37.1 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| Lymph node hyperplasia | Lymph node |
4.12 |
4.25 |
4.19 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Lymphoid tissue hyperplasia - lymphoid | Lung |
10.86 |
7.43 |
9.14 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mammary gland adenocarcinoma | Mammary gland |
1.2 - 35.7 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Mammary gland adenocarcinoma | Mammary gland | calorie restricted |
0.4 - 5.3 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Mammary gland adenoma | Mammary gland |
0.12 |
0 |
0.6 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mammary gland carcinoma | Mammary gland |
0.59 |
0 |
0.3 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mammary gland fibroadenoma | Mammary gland |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast | methylcholanthrene (MCA) |
observed |
References: Shimokado K, Jpn J Cancer Res 1998 Mar;89(3):269-77 |
||||
| Mesodermal cell/mesoblast sarcoma | Uterus - Endometrium - Stroma |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Mesodermal cell/mesoblast sarcoma | Skin |
0.12 - 18.2 |
0.16 - 2.1 |
0.14 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mesodermal cell/mesoblast sarcoma | Liver | calorie restricted |
6.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Mesodermal cell/mesoblast sarcoma | Skin | calorie restricted |
6.7 - 33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Mesodermal cell/mesoblast sarcoma | Abdominal cavity |
0 |
0.12 - 2.1 |
0.06 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mesodermal cell/mesoblast sarcoma | Gallbladder |
2.9 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Mesodermal cell/mesoblast sarcoma | Lung |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mesodermal cell/mesoblast sarcoma | Intestine - Small Intestine |
0.04 |
0.08 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mesodermal cell/mesoblast sarcoma | Uterus |
0.08 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Mesodermal cell/mesoblast sarcoma | Vagina |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Mesodermal cell/mesoblast sarcoma | Thoracic cavity |
0 |
0.12 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mesodermal cell/mesoblast sarcoma - poorly differentiated | Muscle - Striated - Skeletal |
1.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Mesodermal cell/mesoblast sarcoma - poorly differentiated | Muscle - Striated - Skeletal | calorie restricted |
2.5 - 5.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Mesodermal cell/mesoblast sarcoma - unclassified | Liver |
0 |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Mesodermal cell/mesoblast sarcoma - unclassified | Uterus |
0.8 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Mesothelium mesothelioma | Abdominal cavity |
0.08 |
0 - 5.3 |
0.04 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Mesothelium mesothelioma | Thoracic cavity |
0.08 |
0 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Muscle - Smooth leiomyoma | Intestine - Large Intestine |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Muscle - Smooth leiomyoma | Uterus |
0.04 - 7.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Muscle - Smooth leiomyosarcoma | Intestine - Large Intestine |
0 - 0.4 |
0 - 0.08 |
0.04 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Muscle - Smooth leiomyosarcoma | Epididymis |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Muscle - Smooth leiomyosarcoma | Muscle - Smooth |
0 |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus |
0.2 - 10.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Muscle - Smooth leiomyosarcoma | Intestine |
3.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Muscle - Smooth leiomyosarcoma | Uterus | calorie restricted |
6.7 - 33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Muscle - Smooth leiomyosarcoma | Skin |
0.08 |
0.12 |
0.10 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Muscle - Striated - Skeletal rhabdomyosarcoma | Muscle - Striated - Skeletal |
0.08 - 5.9 |
0 |
0.04 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Myoepithelial cell myoepithelioma | Mammary gland |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Neuroblast neuroblastoma | Pancreas |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Nose - Nasal cavity adenocarcinoma | Nose - Nasal cavity |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Nose squamous cell carcinoma | Nose | calorie restricted |
3.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Ovary - Germ cell teratoma | Ovary - Germ cell |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Ovary - Germ cell teratoma | Ovary - Germ cell | calorie restricted |
7.1 - 50.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0.12 - 10.5 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | calorie restricted |
6.7 - 14.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Ovary - Hilus cell tumor | Ovary - Hilus cell |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary adenocarcinoma | Ovary |
0.12 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary adenoma | Ovary |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Ovary adenoma - cystic papillary | Ovary |
1.4 - 7.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Ovary adenoma - cystic papillary | Ovary | calorie restricted |
14.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Ovary adenoma - papillary | Ovary |
0.28 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary adenoma - tubular | Ovary | calorie restricted |
2.9 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Ovary adenoma - tubular | Ovary |
0.08 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary cyst | Ovary |
11.38 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary cystadenoma | Ovary |
1.2 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Ovary lesion | Ovary |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Ovary luteoma | Ovary |
0.08 - 5.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Oviduct lesion | Oviduct |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| PNS - Ganglion - Paraganglion chemodectoma | PNS - Ganglion - Paraganglion |
14.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| PNS - Schwann cell neurofibrosarcoma | Skin |
0.04 |
0.08 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| PNS - Schwann cell neurofibrosarcoma | Intestine - Large Intestine |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| PNS - Schwann cell schwannoma | Skin |
0.08 |
0.04 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| PNS - Schwann cell schwannoma | PNS - Schwann cell |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Pancreas - Duct cyst | Pancreas - Duct |
0.75 |
0.20 |
0.47 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans |
0.08 - 4.5 |
0 - 4.8 |
0.18 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans | calorie restricted |
6.7 |
2.3 - 3.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Pancreas - Islet of Langerhans carcinoma | Pancreas - Islet of Langerhans | calorie restricted |
2.5 |
2.3 - 3.8 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Pancreas - Islet of Langerhans carcinoma | Pancreas - Islet of Langerhans |
0.08 |
0 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pancreas - Islet of Langerhans hyperplasia | Pancreas - Islet of Langerhans |
0.2 |
1.57 |
0.89 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pancreas adenoma | Pancreas |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Parathyroid gland adenoma | Parathyroid gland |
0.04 |
0 - 6.25 |
0.02 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Penis squamous cell carcinoma | Penis | calorie restricted |
3.8 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Peritoneum - Mesentery neoplasm - malignant - anaplastic | Abdominal cavity |
3.1 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Pituitary gland - Pars distalis adenoma | Pituitary gland - Pars distalis |
0 - 100 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Pituitary gland - Pars distalis adenoma | Pituitary gland - Pars distalis | calorie restricted |
0 - 13.3 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Pituitary gland adenocarcinoma | Pituitary gland |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Pituitary gland adenoma | Pituitary gland |
3.01 - 6.9 |
0.12 - 0.4 |
1.56 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pituitary gland carcinoma | Pituitary gland |
0.16 |
0.08 |
0.12 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pituitary gland hyperplasia | Pituitary gland |
0.36 |
0.28 |
observed - 0.32 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Pituitary gland preneoplastic lesion | Pituitary gland |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Pleural cavity tumor | Pleural cavity |
0 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Prostate gland - Anterior lobe adenocarcinoma | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe adenoma | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe cyst - mucinous | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe hyperplasia - epithelial | Prostate gland - Anterior lobe |
0 - 1.39 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe lesion - neoplastic | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe metaplasia - mucinous | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe tumor | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Anterior lobe tumor - granular cell | Prostate gland - Anterior lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe adenocarcinoma | Prostate gland - Dorsolateral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe adenoma | Prostate gland - Dorsolateral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe cyst - mucinous | Prostate gland - Dorsolateral lobe |
0 - 1.36 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe hyperplasia - epithelial | Prostate gland - Dorsolateral lobe |
0.66 - 1.37 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe lesion - neoplastic | Prostate gland - Dorsolateral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe metaplasia - mucinous | Prostate gland - Dorsolateral lobe |
0 - 0.68 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe tumor | Prostate gland - Dorsolateral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Dorsolateral lobe tumor - granular cell | Prostate gland - Dorsolateral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe adenocarcinoma | Prostate gland - Ventral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe adenoma | Prostate gland - Ventral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe cyst - mucinous | Prostate gland - Ventral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe hyperplasia - epithelial | Prostate gland - Ventral lobe |
0 - 2.54 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe lesion - neoplastic | Prostate gland - Ventral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe metaplasia - mucinous | Prostate gland - Ventral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland - Ventral lobe tumor - granular cell | Prostate gland - Ventral lobe |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Prostate gland adenocarcinoma | Prostate gland |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Renal pelvis - Transitional cell papilloma | Renal pelvis - Transitional cell |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Seminal vesicle adenocarcinoma | Seminal vesicle |
0 - 0.68 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Seminal vesicle adenoma | Seminal vesicle |
0 - 0.67 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Seminal vesicle adenoma - papillary | Seminal vesicle |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Seminal vesicle cyst - mucinous | Seminal vesicle |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Seminal vesicle lesion - neoplastic | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Seminal vesicle metaplasia - mucinous | Seminal vesicle |
0 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Seminal vesicle tumor | Seminal vesicle |
0 - observed |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Seminal vesicle tumor - granular cell | Seminal vesicle |
0 - 0.62 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| Skin - Epidermis - Basal cell carcinoma - basal | Skin - Epidermis - Basal cell |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin - Hair follicle - Basal cell trichoepithelioma | Skin - Hair follicle - Basal cell |
0 - 5.3 |
0 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin - Melanocyte melanoma - malignant | Skin - Melanocyte |
0.04 |
0.04 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin adenocarcinoma | Skin |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin adenoma - sebaceous | Skin |
0 |
0.08 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin carcinoma - basosquamous | Skin |
2.7 - 14.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Skin gland - Sebaceous gland adenoma | Skin gland - Sebaceous gland |
0.4 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Skin keratoacanthoma | Skin |
0.04 |
0.04 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin lesion | Skin |
observed |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
||||
| Skin papilloma | Skin |
0.04 |
0.12 |
0.08 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Skin squamous cell carcinoma | Skin | calorie restricted |
5.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Skin squamous cell carcinoma | Skin |
0.04 |
0.12 |
0.08 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Stomach adenocarcinoma | Stomach | calorie restricted |
10.0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Stomach carcinoma | Stomach |
0.04 |
0.04 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Stomach hyperplasia | Stomach |
0.75 |
0.87 |
0.81 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Stomach papilloma | Stomach |
0.28 - 100 |
0.31 - 4.3 |
0.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Stomach papilloma | Stomach | calorie restricted |
6.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Stomach polyp - adenomatous | Stomach |
0.04 |
0.08 |
0.06 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Stomach squamous cell carcinoma | Stomach |
0 - 6.7 |
0.04 - 14.3 |
0.02 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Stomach squamous cell carcinoma | Stomach | calorie restricted |
6.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Testis - Germ cell carcinoma - embryonal | Testis - Germ cell |
0.08 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Testis - Germ cell seminoma | Testis - Germ cell |
0.04 - 0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) |
6.25 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) | calorie restricted |
7.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
0.28 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
0 - 29.4 |
0 - 0.63 |
0.91 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell | calorie restricted |
0 - 6.7 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Thyroid gland - Follicular cell carcinoma | Thyroid gland - Follicular cell |
0.24 |
0.28 |
0.26 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Thyroid gland - Follicular cell hyperplasia - cystic | Thyroid gland - Follicular cell |
1.23 |
0.9 |
1.07 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Thyroid gland - Follicular cell hyperplasia - follicular | Thyroid gland - Follicular cell |
1.55 |
0.59 |
1.07 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Thyroid gland - Medulla - C cell adenoma | Thyroid gland - Medulla - C cell |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Thyroid gland - Medulla - C cell carcinoma | Thyroid gland - Medulla - C cell | calorie restricted |
5.0 - 33.3 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Thyroid gland - Medulla - C cell carcinoma | Thyroid gland - Medulla - C cell |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Thyroid gland adenoma | Thyroid gland |
0.8 |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Thyroid gland hyperplasia | Thyroid gland |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Thyroid gland neoplasm | Thyroid gland |
12.0 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Thyroid gland neoplasm | Thyroid gland | calorie restricted |
2.6 |
0 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| Thyroid gland preneoplastic lesion | Thyroid gland |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Tongue squamous cell carcinoma | Tongue |
0 - 7.1 |
0.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Urethra adenoma | Urethra |
0 |
0.04 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Urinary bladder adenoma - papillary | Urinary bladder |
0.04 |
0 |
0.02 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Urinary bladder hyperplasia - epithelial | Urinary bladder |
1.15 |
1.26 |
1.2 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Urinary bladder papilloma | Urinary bladder |
0.08 |
0 |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||
| Urinary bladder tumor | Urinary bladder |
0 |
0 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| Uterus - Endometrium - Stroma polyp | Uterus - Endometrium - Stroma |
0.4 - 0.52 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus adenocarcinoma | Uterus |
0.08 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus adenoma | Uterus |
0.24 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus cyst | Uterus |
5.79 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus hyperplasia | Uterus |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus hyperplasia - cystic | Uterus |
35.01 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus lesion | Uterus |
observed |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| Uterus polyp | Uterus |
1.4 - 21.4 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||||
| Uterus polyp | Uterus | calorie restricted |
2.9 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Vagina adenocarcinoma | Vagina |
0.4 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
|||||
| Vagina squamous cell carcinoma | Vagina | calorie restricted |
6.7 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
||||
| Vagina squamous cell carcinoma | Vagina |
0.04 |
References: Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
|||||
| (Unspecified organ) histiocytoma - fibrous - malignant | (Unspecified organ) |
0 - 1.2 |
0.4 - 3.3 |
References: Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| (Unspecified organ) hyperplasia | Prostate gland - Anterior lobe |
0 - 2.74 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| (Unspecified organ) neoplasm | (Unspecified organ) |
0 - 100 |
0 - 100 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 ⋅ Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
||||
| (Unspecified organ) neoplasm | (Unspecified organ) | calorie restricted |
0 - 100 |
0 - 100 |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
|||
| (Unspecified organ) neoplasm - malignant - anaplastic | (Unspecified organ) |
observed |
References: Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 Sites of Metastasis: Lung |
|||||
| (Unspecified organ) tumor | (Unspecified organ) |
44.6 - 65.3 |
16.9 - 76.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 ⋅ Tamano S, Toxicol Pathol 1988;16(3):321-6 |
||||
| (Unspecified organ) tumor | (Unspecified organ) | Cyclosporin A |
56.1 |
25.9 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | X-radiation |
47.1 |
20.0 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | X-radiation ⋅ Cyclosporin A |
59.3 |
20.5 |
References: Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
|||
| (Unspecified organ) tumor | Prostate gland - Dorsolateral lobe |
0 - 2.83 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| (Unspecified organ) tumor | Prostate gland - Ventral lobe |
0 - 2.54 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| (Unspecified organ) tumor | Seminal vesicle |
0 - 2.7 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| (Unspecified organ) tumor | Ampullary gland |
0 - 9.09 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||
| (Unspecified organ) tumor | Prostate gland - Anterior lobe |
0.87 |
References: Suwa T, Toxicol Pathol 2002 Mar-Apr;30(2):228-34 |
|||||